(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BLUDIGO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BLUDIGO

ST13

US500000097267309

Class

5

Filing

97267309

Registration

7347784

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

04/02/2024

Trademark type

Word

Nice classes

5

Filing date

02/15/2022

Registration date

04/02/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/02/2024

Last transaction

04/02/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/23/2022

First use in commerce

09/23/2022

Drawing code

4

Owner type

99

Owner location

Marseille, FR

Examiner

MILLER, CHARLES

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

PROVEPHARM LIFE SOLUTIONS

Representatives

Aaron Y. Silverstein SAUNDERS & SILVERSTEIN LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations in the nature of indigo carmine solutions for marking tissue by injection in surgery and internal medicinefor marking tissue of the digestive system by oralanal or injectable administrationfor oral and topical antiseptic treatmentfor marking and functional verification of gynecological and urological systems by instillationinjection or local application; chemical preparations in the nature of indigo carmine for medical use for marking tissue by injection in surgery and internal medicinefor marking tissue of the digestive system by oralanal or injectable administrationfor oral and topical antiseptic treatmentfor marking and functional verification of gynecological and urological systems by instillationinjection or local application; chemical preparations in the nature of indigo carmine solutions for medical use for marking tissue by injection in surgery and internal medicinefor marking tissue of the digestive system by oralanal or injectable administrationfor oral and topical antiseptic treatmentfor marking and functional verification of gynecological and urological systems by instillationinjection or local application; indigo carmine solutions for use as a marker during gastro-intestinal endoscopy; indigo carmine solutions used as a contrast solution for medical imaging procedures; indigo carmine solutions for medical diagnostic purposes for viewing and marking tissue; indigo carmine solutions used as an aid in visualization of topographic irregularities and in delineation of polypoid or flat lesionsincluding adenomas; indigo carmine solutions used for polyps or lesions resection medicines for tissue staining; indigo carmine solutions for use as a marker during visceral surgery; indigo carmine solutions for the detection of amniotic fluid leaks; indigo carmine solutions for use as a marker during cystoscopy and ureteral catheterization; indigo carmine solutions for use as a marker during vessel delineation and tumor localization procedures; clinical medical reagents; diagnostic preparations in vials for medical use; drug delivery agents in the form of filled vials that facilitate the delivery of pharmaceutical preparations

Publications

History of USPTO decisions and trademark events.

23 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/02/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/02/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

02/29/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/28/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/27/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/27/2024

ALIE

ASSIGNED TO LIE

02/27/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/05/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/16/2023

GNRT

NON-FINAL ACTION E-MAILED

08/16/2023

CNRT

SU - NON-FINAL ACTION - WRITTEN

08/16/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/07/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/05/2023

IUAF

USE AMENDMENT FILED

05/11/2023

EISU

TEAS STATEMENT OF USE RECEIVED

05/11/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/04/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/07/2023

PUBO

PUBLISHED FOR OPPOSITION

02/07/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/18/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/30/2022

DOCK

ASSIGNED TO EXAMINER

11/30/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/18/2022

NWAP

NEW APPLICATION ENTERED

02/18/2022

Continuous trademark protection

Get notified about every new filing that threatens BLUDIGO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.